Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ambu Transaction in Own Shares 2016

Mar 18, 2016

3353_rns_2016-03-18_99af1f86-0950-4f63-b104-16d72c6b4dbc.pdf

Transaction in Own Shares

Open in viewer

Opens in your device viewer

Ambu
Ideas that work for life

img-0.jpeg

Buyback programme

On 11 November 2015, Ambu initiated two parallel share buyback programmes for the purpose of hedging share-based incentive programmes.

The share buyback programmes, which run in the period 11 November 2015 and ending on 30 April 2016 at the latest, comprise a total share buyback of DKK 175 million, of which DKK 60 million will be purchased in accordance with the Safe Harbour provisions of European Commission Regulation No. 2273/2003 of 22 December 2003, while the remainder, DKK 115 million, will be purchased in will be purchased in the course of the period, but outside the Safe Harbour rules.

Under the share buyback programmes, the following transactions were conducted in the period 11 to 17 March 2016:

Shares bought under the Safe Harbour rules:

Date Number of B shares Average market price Transaction value
Accumulated latest announcement 241,707 201.1 48,599,727
11 March 2016 2,000 228.4 456,704
14 March 2016 3,000 236.1 708,432
15 March 2016 2,000 233.9 467,821
16 March 2016 2,000 230.3 460,530
17 March 2016 3,600 223.5 804,511
Accumulated under the programme 254,307 202.5 51,497,725

Shares bought outside the Safe Harbour rules:

Date Number of B shares Average market price Transaction value
Accumulated latest announcement 562,000 204.6 114,968,894
11 March 2016 - - -
14 March 2016 - - -
15 March 2016 - - -
16 March 2016 - - -
17 March 2016 - - -
Accumulated under the programme 562,000 204.6 114,968,894

Ambu
Company announcement no. 26 2015/16
18 March 2016


Ambu*
Ideas that work for life

Following the above transactions, Ambu owns a total of 1,060,207 Class B shares with a nominal value of DKK 2.5 each, corresponding to 2.19% of the share capital. The total number of Class A and Class B shares in the company is 48,352,320 including treasury shares.

Contact

Lars Marcher, President & CEO, tel. +45 5136 2490, email: [email protected]

Ambu A/S
Baltorpbakken 13
DK-2750 Ballerup
CVR no.: 63 64 49 19
Tel. +45 7225 2000
www.ambu.com

About Ambu

Since 1937, breakthrough ideas have fuelled our work on bringing efficient healthcare solutions to life. This is what we create within our fields of excellence – Anaesthesia, Patient Monitoring & Diagnostics, and Emergency Care. Millions of patients and healthcare professionals worldwide depend on the functionality and performance of our products. We are dedicated to improve patient safety and determined to advance single-use devices. The manifestations of our efforts range from early inventions like the Ambu Bag™ resuscitator and the legendary BlueSensor™ electrodes to our newest landmark solutions like the aScope™ endoscope – the world's first single-use flexible video scope. Our commitment to bringing new ideas and superior service to our customers has made Ambu one of the most recognized medical companies in the world. Headquartered near Copenhagen in Denmark, Ambu employs approximately 2,300 people in Europe, North America and the Asia Pacific. For more information, please visit www.ambu.com.

Ambu

Company announcement no. 26 2015/16
18 March 2016
Page 2 of 2